|Bid||194.69 x 800|
|Ask||213.51 x 800|
|Day's range||204.51 - 210.98|
|52-week range||198.11 - 285.61|
|Beta (5Y monthly)||1.46|
|PE ratio (TTM)||37.33|
|Earnings date||25 Jul 2022 - 29 Jul 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||263.13|
IQVIA (IQV) rides on a solid healthcare-specific global IT infrastructure and analytics-driven clinical development skills. However, a weak balance sheet is worrisome.
Mastercard's (MA) first-quarter results reflect improved GDV and switched transactions, partly offset by higher operating expenses.
At this time, I would like to welcome everyone to the IQVIA first quarter 2022 earnings conference call. With me today are Ari Bousbib, chairman and chief executive officer; Ron Bruehlman, executive vice president and chief financial officer; Eric Sherbet, executive vice president and general counsel; Mike Fedock, senior vice president, financial planning and analysis; and Bryan Stengel, associate director, investor relations.